Effects of some drugs on mobilization of transmitter substances in neuromuscular junction
Nobe, S.; Kodama, K.; Suemori, I.; Yoshida, Y.; Adachi, H.
Masui. Japanese Journal of Anesthesiology 20(10): 937-938
1971
ISSN/ISBN: 0021-4892 PMID: 4331438 Document Number: 42732
Document emailed within 1 workday
Related Documents
Brumback, R.A. 1981: The neuromuscular junction. Part I: physiology and the effects of drugs and toxins American Family Physician 23(1): 188-192Carmignani, M.; Scoppetta, C.; Ranelletti, F.O.; Tonali, P. 1984: Adverse interaction between acetazolamide and anticholinesterase drugs at the normal and myasthenic neuromuscular junction level International Journal of Clinical Pharmacology Therapy and Toxicology 22(3): 140-144
Sellin, L.C.; Kauffman, J.A.; Dasgupta, B.R. 1983: Comparison of the effects of botulinum neurotoxin types a and e at the rat neuromuscular junction Medical Biology 61(2): 120-125
Audibert-Benoit, M.L. 1973: Effects of an intracellular injection of tetraethylammonium ion upon synaptic transmission in the neuromuscular junction of the frog Journal de Physiologie 67(3): 330a
Babakova, L.L.; Krasnov, I.B.; Pozdniakov, O.M. 2008: Impact of 3-month simulation of the microgravity effects on the neuromuscular junction structure in rat's m. soleus Aviakosmicheskaia i Ekologicheskaia Meditsina 42(4): 31-35
Tsai, M.C.; Albuquerque, E.X.; Aronstam, R.S.; Eldefrawi, A.T.; Eldefrawi, M.E.; Triggle, D.J. 1980: Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle Molecular Pharmacology 18(2): 159-166
Mihály, A. 1982: Histochemistry and functional significance of putative neocortical transmitter substances: a review Zeitschrift für Mikroskopisch-Anatomische Forschung 96(6): 916-936
Pozaniakov, O.M.; Babakova, L.L.; Kolomenskaia, E.A.; Kuz'min, N.V. 1975: Ultrastructure of the neuromuscular junction in myasthenia Arkhiv Patologii 37(10): 55-63
Takamori, M.; Sakato, S.; Matsubara, S.; Okumura, S. 1982: Function and structure of the neuromuscular junction Nihon Rinsho. Japanese Journal of Clinical Medicine 40(7): 1454-1458
Chauplannaz, G.; Vial, C. 2000: Electrodiagnosis of neuromuscular junction diseases Revue Neurologique (Paris) 156(1): 76-81
Giniatullin, R.A.; Sokolova, E.M. 1998: Modulating role of ATP in the neuromuscular junction Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 84(10): 1132-1138
Fardeau, M.; Dreyfus, P. 1975: Neuromuscular junction. History and present-day knowledge La Revue du Praticien 25(59): 4663-4667
Horvat-Znidarsic, I.; Suput, D.; Gubensek, F. 2000: The effect of ammodytin L on frog neuromuscular junction Pflugers Archiv: European Journal of Physiology 439(3 Suppl): R102-R103
Botvin, J.G.; Otvin, J.G.; Ditunno, J.F.; Herbison, G.J. 1975: Mobilization of a patient with progressive neuromuscular disease and lower extremity fractures Archives of Physical Medicine and Rehabilitation 56(7): 317-319
Madden, K.S.; Van der Kloot, W. 1985: Indomethacin, prostaglandin E2 and transmission at the frog neuromuscular junction Journal of Pharmacology and Experimental Therapeutics 232(2): 305-314
Wilson, D.F.; Skirboll, L.R. 1974: Basis for posttetanic potentiation at the mammalian neuromuscular junction American Journal of Physiology 227(1): 92-95
Karcsú, S.; Tóth, L.; Katona, M. 1975: Electrocytochemical study of the neuromuscular junction in the process of ontogenesis Morphologiai Es Igazsagugyi Orvosi Szemle 15(2): 105-112
Hemsworth, B.A.; Cholakis, J.M. 1972: Mechanisms of action of a hemicholinium analogue at the neuromuscular junction Journal of Pharmacy and Pharmacology 24: Suppl: 147p
Hironaka, T. 1970: Effect of dimorpholamine (Th 1064) on crayfish neuromuscular junction Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 66(3): 293-303
Hudson, C.S.; Rash, J.E.; Tiedt, T.N.; Albuquerque, E.X. 1978: Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure Journal of Pharmacology and Experimental Therapeutics 205(2): 340-356